Summit’s Ridinilazole preserves gut microbiome of patients with C. difficile infection

Image: Summit’s ridinilazole demonstrates superior preservation of gut microbiome in phase 2 trial compared to vancomycin. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.